TITAN-HCC: Neoadjuvant and Adjuvant QL1706 With TACE in Resectable Hepatocellular Carcinoma Beyond Milan Criteria
NCT07268131
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Hepatocellular Carcinoma (HCC)
Interventions
COMBINATION_PRODUCT:
TACE+QL1706
Sponsor
Fudan University